Morphin Zur Anwendung Bei Kindern Und Erwachsenen Merck (Morphine Hydrochloride Trihydrate)

Morphine works by binding to μ‑opioid receptors in the brain, spinal cord and peripheral nervous system. This binding activates inhibitory G‑protein pathways, reducing the release of excitatory neurotransmitters and decreasing neuronal firing. The net effect is a lowered perception of pain, increased pain threshold, and modulation of the emotional response to painful stimuli.

The appropriate dose of morphine is individualized by the prescribing clinician based on factors such as the patient’s age, weight, pain severity, prior opioid exposure, renal and hepatic function, and the intended route of administration. Dosage adjustments are made to achieve adequate analgesia while minimizing adverse effects, and the regimen is documented in the patient’s medical record.

Safety data for morphine in pregnancy and lactation are limited. The drug crosses the placenta and may cause neonatal respiratory depression if administered near delivery. It is also excreted in breast milk and could affect the infant. Clinicians must weigh potential benefits against risks and consider alternative therapies when possible.

To order Morphin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Morphine is considered the reference opioid for potency and is often used to benchmark other agents. Compared with synthetic opioids such as fentanyl or hydromorphone, morphine has a longer onset time but a well‑characterized safety profile. Its metabolism produces active metabolites that may accumulate in renal impairment, a factor that influences drug selection.

Morphin should be stored below 25 °C in its original packaging. The container must be kept tightly closed, protected from light, and stored away from moisture. Do not freeze the product. If the solution appears cloudy or contains particles, it should be discarded according to local regulations.

Morphin is supplied as a sterile injectable solution and can be given by epidural, intramuscular, or intrathecal injection. The specific route, volume, and concentration are determined by the treating physician based on the clinical situation. Administration should be performed by qualified healthcare professionals in a setting equipped for monitoring vital signs.

The most serious risks include respiratory depression, which can be life‑threatening, especially after high doses or when combined with other depressants. Severe hypotension, anaphylactic reactions, and the development of physical dependence or opioid use disorder are also critical concerns. Prompt recognition and appropriate monitoring are essential to mitigate these hazards.

Morphine is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, in those with severe respiratory insufficiency, and in individuals who have taken monoamine oxidase inhibitors within the past 14 days. Caution is also advised for patients with uncontrolled asthma, paralytic ileus, or significant head injury.